V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 160010926 | 160015147 | 1.79 | 67.7 | Palliative (P) | 2020-05-02 | 2020-05-26 | Trabectedin | 02 | N | TRABECTEDIN | 101546658 |
| 160010930 | 160015148 | 1.63 | 85.4 | null | 2020-04-26 | 2020-04-27 | DOXORUBICIN | 02 | null | TRIAL UNSPECIFIED | 101179990 |
| 160010938 | 160015149 | 1.82 | null | Palliative (P) | 2017-06-01 | 2017-06-26 | NIVOLUMAB | 02 | N | NIVOLUMAB | 101163903 |
| 160010940 | 160015150 | 1.62 | 68.8 | null | 2018-11-12 | 2018-11-12 | Doxorubicin 75mg/m2 | 02 | null | DOXORUBICIN | 100202088 |
| 160010946 | 160015151 | 1.65 | 80.8 | Neo-adjuvant (N) | 2020-02-05 | 2020-02-20 | Trabectedin | null | N | TRABECTEDIN | 100471538 |
| 160010956 | 160015153 | 1.68 | 104.8 | null | 2021-03-19 | 2021-03-21 | Trabectedin | 02 | null | TRABECTEDIN | 100719891 |
| 160010967 | 160015154 | 1.58 | 57.45 | null | 2021-09-28 | 2021-10-05 | NIVOLUMAB | 02 | null | NIVOLUMAB | 100595017 |
| 160010978 | 160015155 | 1.65 | 110 | Palliative (P) | 2016-09-13 | 2016-09-13 | DOXORUBICIN | 02 | N | DOXORUBICIN | 100368242 |
| 160010982 | 160015156 | 1.72 | 106 | Palliative (P) | 2021-11-15 | 2021-11-18 | Trabectedin | 02 | N | TRABECTEDIN | 101429165 |
| 160010989 | 160015157 | 1.56 | 95.8 | Palliative (P) | 2020-01-27 | 2020-01-27 | Trial Unspecified | 02 | N | TRIAL UNSPECIFIED | 100103522 |
| 160010991 | 160015158 | 0 | 103.2 | null | 2017-12-24 | 2018-01-10 | Trial Unspecified | 01 | null | TRIAL UNSPECIFIED | 101502634 |
| 160010995 | 160015159 | 1.68 | 52.8 | Palliative (P) | 2021-06-05 | 2021-08-01 | DOXORUBICIN | 02 | null | TRABECTEDIN | 100636812 |
| 160010998 | 160015160 | 1.65 | 65.7 | Palliative (P) | 2019-09-10 | 2019-09-17 | Doxorubicin 75mg/m2 | 02 | N | TRIAL UNSPECIFIED | 100121599 |
| 160011017 | 160015161 | 1.73 | 86.8 | null | 2018-07-21 | 2018-09-25 | VINORELBINE | 02 | null | VINORELBINE | 101098107 |
| 160011030 | 160015163 | 1.54 | 87 | Palliative (P) | 2016-10-27 | 2016-10-28 | Trial Unspecified | 01 | null | TRIAL UNSPECIFIED | 101390485 |
| 160011036 | 160015164 | 1.62 | 103.4 | 03 | 2020-01-11 | 2020-01-18 | Vinorelbine (weekly iv) | 02 | N | VINORELBINE | 100292094 |
| 160011040 | 160015165 | 1.62 | 73.8 | null | 2020-12-02 | 2020-12-07 | Doxorubicin 75mg/m2 | 02 | null | DOXORUBICIN | 100770876 |
| 160011045 | 160015166 | 1.5 | 89 | null | 2020-08-28 | 2020-11-02 | DOXORUBICIN | 02 | null | DOXORUBICIN | 101764618 |
| 160011047 | 160015167 | 1.89 | 75 | Palliative (P) | 2019-02-20 | 2019-02-20 | NIVOLUMAB | 02 | N | NIVOLUMAB | 101529942 |
| 160011048 | 160015168 | 1.73 | 67.4 | Palliative (P) | 2020-12-17 | 2021-09-26 | NIVOLUMAB | 02 | N | NIVOLUMAB | 100039813 |
| 160011050 | 160015169 | 1.63 | null | null | 2020-01-22 | 2020-02-08 | Trabectedin | null | null | TRABECTEDIN | 100073079 |
| 160011052 | 160015170 | 1.65 | 83 | Palliative (P) | 2019-03-15 | 2019-03-31 | DOXORUBICIN | 02 | N | TRIAL UNSPECIFIED | 100682129 |
| 160011071 | 160015171 | 1.75 | 76 | null | 2022-03-09 | 2022-03-15 | Trabectedin | 02 | null | TRABECTEDIN | 101394943 |
| 160011072 | 160015172 | 1.8 | 90 | null | 2013-11-11 | 2013-12-09 | Trial Unspecified | 01 | null | TRIAL UNSPECIFIED | 101594014 |
| 160011080 | 160015173 | 1.66 | 72.4 | Palliative (P) | 2018-12-29 | 2019-08-19 | DOXORUBICIN | 02 | N | DOXORUBICIN | 100320216 |
| 160011085 | 160015174 | 1.85 | 58.1 | Palliative (P) | 2020-05-31 | 2020-06-06 | NIVOLUMAB | 02 | N | NIVOLUMAB | 100524697 |
| 160011088 | 160015175 | 1.72 | 70 | Palliative (P) | 2021-02-01 | 2021-02-16 | NIVOLUMAB | 02 | null | NIVOLUMAB | 100617340 |
| 160011091 | 160015176 | 1.73 | 74.9 | null | 2018-12-12 | 2019-01-02 | Doxorubicin 75mg/m2 | 02 | null | TRABECTEDIN | 100919429 |
| 160011097 | 160015177 | 1.73 | 63 | Palliative (P) | 2021-02-02 | 2021-05-09 | Trabectedin | 02 | N | TRABECTEDIN | 100957477 |
| 160011113 | 160015178 | 1.74 | 46.7 | null | null | 2018-05-09 | Trial Unspecified | 01 | null | TRIAL UNSPECIFIED | 100103739 |
| 160011132 | 160015179 | null | 77.8 | Palliative (P) | 2020-10-30 | 2020-11-26 | NIVOLUMAB | 02 | N | NIVOLUMAB | 100466360 |
| 160011133 | 160015180 | null | 71.3 | Palliative (P) | 2018-03-11 | 2018-03-16 | NIVOLUMAB | 02 | N | NIVOLUMAB | 101028982 |
| 160011140 | 160015181 | 1.53 | 71.3 | Palliative (P) | 2021-09-11 | 2022-01-05 | Trial Unspecified | 02 | N | TRIAL UNSPECIFIED | 101448829 |
| 160011143 | 160015182 | 1.64 | 66.3 | Palliative (P) | 2019-06-29 | 2019-07-24 | Vinorelbine (oral) | 02 | null | VINORELBINE | 100055983 |
| 160011145 | 160015183 | 1.85 | 59.4 | null | 2021-05-01 | 2021-07-22 | DOXORUBICIN | 02 | null | VINORELBINE | 101660404 |
| 160011167 | 160015184 | 1.75 | 70 | null | 2021-06-26 | 2021-07-01 | Vinorelbine (oral) | 02 | null | VINORELBINE | 101685869 |
| 160011172 | 160015185 | null | 76.9 | null | 2020-05-15 | 2020-05-29 | Trial Unspecified | 02 | null | TRIAL UNSPECIFIED | 100316774 |
| 160011176 | 160015186 | 1.8 | 99.8 | Palliative (P) | 2019-06-15 | 2019-08-03 | Trial Unspecified | 02 | N | TRIAL UNSPECIFIED | 100042544 |
| 160011183 | 160015187 | 1.81 | 71.2 | Adjuvant (A) | 2021-03-22 | 2021-03-24 | Trabectedin | 02 | N | TRABECTEDIN | 100532647 |
| 160011185 | 160015188 | 1.75 | 81.4 | Palliative (P) | 2021-09-14 | 2021-09-21 | DOXORUBICIN | 02 | N | NIVOLUMAB | 100711398 |
| 160011208 | 160015190 | 1.82 | 61.5 | Palliative (P) | 2018-09-17 | 2018-09-21 | Vinorelbine (oral) | 02 | N | VINORELBINE | 101222925 |
| 160011212 | 160015191 | 1.47 | 64 | Palliative (P) | null | null | VINORELBINE | 02 | null | VINORELBINE | 101105629 |
| 160011214 | 160015192 | 1.6 | 65.9 | null | 2018-05-04 | 2018-05-06 | VINORELBINE | 02 | null | VINORELBINE | 101561539 |
| 160011219 | 160015193 | 1.65 | 84.2 | Palliative (P) | 2020-11-03 | 2020-11-11 | Trabectedin | 02 | N | TRABECTEDIN | 101378075 |
| 160011231 | 160015194 | 1.71 | 51.5 | Palliative (P) | 2019-01-25 | 2019-01-27 | Doxorubicin 75mg/m2 | 02 | N | DOXORUBICIN | 100125857 |
| 160011232 | 160015195 | 1.75 | 45.05 | null | 2018-10-21 | 2018-10-28 | Trial Unspecified | 01 | null | TRIAL UNSPECIFIED | 100795137 |
| 160011236 | 160015196 | 1.7 | 73.5 | Palliative (P) | 2021-05-14 | 2021-05-23 | Doxorubicin 75mg/m2 | 02 | N | DOXORUBICIN | 101649202 |
| 160011237 | 160015197 | 1.72 | 63 | Palliative (P) | 2019-04-26 | 2019-05-09 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 100742176 |
| 160011241 | 160015198 | null | 72.5 | Palliative (P) | 2022-03-28 | 2022-03-28 | NIVOLUMAB | 02 | N | NIVOLUMAB | 100390035 |
| 160011247 | 160015199 | 1.72 | 65 | Palliative (P) | 2018-02-02 | 2018-02-10 | Vinorelbine (oral) | null | N | VINORELBINE | 101578998 |